Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -28.69%12.08M | -42.79%3.39M | -68.53%1.92M | 6.76%3.46M | 100.02%3.3M | -22.46%16.94M | 91.29%5.93M | -20.74%6.12M | -45.13%3.24M | -67.78%1.65M |
Selling and administrative expenses | -47.04%6.26M | -52.71%2.29M | -83.09%780.96K | -22.91%1.5M | 306.59%1.69M | 6.67%11.82M | 177.38%4.84M | -5.92%4.62M | -26.34%1.95M | -76.69%415.45K |
-General and administrative expense | -47.04%6.26M | -52.71%2.29M | -83.09%780.96K | -22.91%1.5M | 306.59%1.69M | 6.67%11.82M | 177.38%4.84M | -5.92%4.62M | -26.34%1.95M | -76.69%415.45K |
Research and development costs | 13.71%5.82M | 1.00%1.11M | -23.55%1.14M | 51.54%1.96M | 30.56%1.61M | -52.45%5.12M | -19.30%1.1M | -46.68%1.5M | -60.39%1.29M | -63.02%1.24M |
Operating profit | 28.69%-12.08M | 42.79%-3.39M | 68.53%-1.92M | -6.76%-3.46M | -100.02%-3.3M | 22.46%-16.94M | -91.29%-5.93M | 20.74%-6.12M | 45.13%-3.24M | 67.78%-1.65M |
Net non-operating interest income expense | -103.75K | 0 | -92.75K | -11K | 0 | 0 | ||||
Non-operating interest expense | --103.75K | --0 | --92.75K | --11K | ---- | ---- | ---- | --0 | --0 | ---- |
Other net income (expense) | -93.35%116.46K | -99.66%4.65K | -91.18%10.65K | -84.91%19.13K | -37.15%82.03K | 800.29%1.75M | 1,093.69%1.37M | 64.69%120.64K | 554.07%126.72K | 1,090.15%130.53K |
Special income (charges) | ---- | ---- | ---- | ---- | ---- | --1.25M | ---- | ---- | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---1.25M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -76.72%116.46K | -96.20%4.65K | -91.18%10.65K | -84.91%19.13K | -37.15%82.03K | 157.33%500.28K | 6.45%122.39K | 64.69%120.64K | 554.07%126.72K | 1,090.15%130.53K |
Income before tax | 20.56%-12.07M | 25.68%-3.39M | 66.53%-2.01M | -10.84%-3.45M | -111.80%-3.22M | 29.84%-15.19M | -52.71%-4.56M | 21.56%-5.99M | 47.10%-3.11M | 70.40%-1.52M |
Income tax | 0 | 0 | ||||||||
Net income | 20.56%-12.07M | 25.68%-3.39M | 66.53%-2.01M | -10.84%-3.45M | -111.80%-3.22M | 29.84%-15.19M | -52.71%-4.56M | 21.56%-5.99M | 47.10%-3.11M | 70.40%-1.52M |
Net income continuous Operations | 20.56%-12.07M | 25.68%-3.39M | 66.53%-2.01M | -10.84%-3.45M | -111.80%-3.22M | 29.84%-15.19M | -52.71%-4.56M | 21.56%-5.99M | 47.10%-3.11M | 70.40%-1.52M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 20.56%-12.07M | 25.68%-3.39M | 66.53%-2.01M | -10.84%-3.45M | -111.80%-3.22M | 29.84%-15.19M | -52.71%-4.56M | 21.56%-5.99M | 47.10%-3.11M | 70.40%-1.52M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 20.56%-12.07M | 25.68%-3.39M | 66.53%-2.01M | -10.84%-3.45M | -111.80%-3.22M | 29.84%-15.19M | -52.71%-4.56M | 21.56%-5.99M | 47.10%-3.11M | 70.40%-1.52M |
Basic earnings per share | 78.10%-71 | 94.16%-5.6928 | 91.60%-10.75 | 34.21%-43.75 | -111.54%-68.75 | 29.85%-324.25 | -50.58%-97.5 | 21.23%-128 | 46.80%-66.5 | 70.45%-32.5 |
Diluted earnings per share | 78.10%-71 | 94.16%-5.6928 | 91.60%-10.75 | 34.21%-43.75 | -111.54%-68.75 | 29.85%-324.25 | -50.58%-97.5 | 21.23%-128 | 46.80%-66.5 | 70.45%-32.5 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |